KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Other Non Operating Income: 2009-2024

Historic Other Non Operating Income for Nektar Therapeutics (NKTR) over the last 16 years, with Dec 2024 value amounting to -$390,000.

  • Nektar Therapeutics' Other Non Operating Income fell 0.83% to -$121,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $270,000, marking a year-over-year increase of 104.09%. This contributed to the annual value of -$390,000 for FY2024, which is 93.76% up from last year.
  • Latest data reveals that Nektar Therapeutics reported Other Non Operating Income of -$390,000 as of FY2024, which was up 93.76% from -$6.2 million recorded in FY2023.
  • Nektar Therapeutics' 5-year Other Non Operating Income high stood at $33.4 million for FY2022, and its period low was -$8.0 million during FY2021.
  • For the 3-year period, Nektar Therapeutics' Other Non Operating Income averaged around $8.9 million, with its median value being -$390,000 (2024).
  • In the last 5 years, Nektar Therapeutics' Other Non Operating Income slumped by 143.88% in 2021 and then skyrocketed by 516.64% in 2022.
  • Yearly analysis of 5 years shows Nektar Therapeutics' Other Non Operating Income stood at $18.3 million in 2020, then crashed by 143.88% to -$8.0 million in 2021, then surged by 516.64% to $33.4 million in 2022, then plummeted by 118.69% to -$6.2 million in 2023, then spiked by 93.76% to -$390,000 in 2024.